BIS-2-(5-PHENYLACETAMIDO-1,3,4-THIADIAZOL-2-YL)ETHYL SULFIDE, 95%, 1g

2-(piperazin-1-ylcarbonyl)-1H-indole, 1g

5-Bromopyrimidine-2-carboxylic acid, 95.0%, 10g

Trimethylhexamethylenediamine (2,2,4- and 2,4,4- mixture)>99.0%(GC)(T)500mL

Ethyl 2-(2,4-difluoro-phenoxy)acetate, 97.0%, 250mg

6-BROMO-1H-INDAZOL-4-AMINE, 95%, 100g

1-(2-Bromoethyl)pyrrolidine hydrobromide, 97.0%, 1g

5-Chloro-4,6-dimethylnicotinonitrile, 95.0%, 250mg

Benzo[g]quinoxaline, 98%, 1g

Tin(II) Iodide [for Perovskite precursor]>97.0%(T)1g

2-Iodonaphthalene, 95.0%, 1g

(4-((2-Chlorobenzyl)oxy)-3,5-dimethylphenyl)boronic acid, 95%, 250mg

(2S,3S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 250mg